Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 189,402 |
|
|||||
| News | - | ||||||
| Day High | 49.00 | Low High |
|||||
| Day Low | 47.32 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Janux Therapeutics Inc | JANX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 0.08% | 48.00 | 12:54:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 48.80 | 47.32 | 49.00 | 47.96 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,007 | 189,402 | $ 48.14 | $ 9,118,263 | - | 5.65 - 58.6936 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:55:35 | 1 | $ 47.9606 | USD |
Janux Therapeutics (JANX) Options Flow Summary
Janux Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.48B | 51.66M | - | 8.08M | -58.29M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Janux Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JANX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 47.06 | 56.27 | 47.00 | 50.79 | 1,273,033 | 0.94 | 2.00% |
| 1 Month | 40.15 | 56.27 | 34.6425 | 45.06 | 771,276 | 7.85 | 19.55% |
| 3 Months | 9.60 | 58.6936 | 7.79 | 43.62 | 940,197 | 38.40 | 400.00% |
| 6 Months | 7.74 | 58.6936 | 5.65 | 39.13 | 500,519 | 40.26 | 520.16% |
| 1 Year | 15.18 | 58.6936 | 5.65 | 34.16 | 306,633 | 32.82 | 216.21% |
| 3 Years | 34.00 | 58.6936 | 5.65 | 28.32 | 182,828 | 14.00 | 41.18% |
| 5 Years | 34.00 | 58.6936 | 5.65 | 28.32 | 182,828 | 14.00 | 41.18% |
Janux Therapeutics Description
| Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. |
